DuPa VACCINE® – Inactivated Avian paramyxovirus type 1 (APMV -1) vaccine for the prophylactic immunization against Newcastle Disease
FOR ANIMAL TREATMENT ONLY
DESCRIPTION
This vaccine contains inactivated, adjuvanted strains of Avian paramyxovirus type 1 virus grown in embryonated chicken eggs. It is presented as a liquid form and each mL contains 320 Haemagglutination unit / ml of Avian paramyxovirus type 1 strains. The vaccine also contains 0.003g/mL of Tris base, 0.0002g/mL of potassium chloride, 0.008g/mL of sodium chloride, 0.000006g/mL of β propiolactone, 0.012g/mL of Aluminium hydroxide and 0.012g/mL of Magnesium hydroxide.
INDICATIONS
For the prophylactic immunization of avians against Newcastle disease.
VACCINATION PROGRAMMES
For birds of all ages, but preferentially used in young birds of 4–6 weeks old to provide individual immunity against Newcastle disease.
RECOMMENDED DOSE AND SCHEDULE
The primary course of immunization includes two vaccinations, a first dose and a second dose after 4 weeks (booster). Each dose is 1.0 mL and should be administered by subcutaneous route to the dorsal part of the bird’s neck, observing aseptic precautions.
An annual booster immunization is required not more than 1 year from the primary course.
CONTRA-INDICATIONS AND WARNING
There are no known health hazards associated with this product. In 1% of vaccinated birds, a small swelling at the injection site is observed. The swelling recedes after 2 to 3 days. DuPa vaccine should always be administered in the dorsal part of the bird’s neck and not near the leg as it may cause lameness for a couple of days.
PHARMACEUTICAL PRECAUTIONS AND STORAGE
Vaccine should be stored refrigerated (between +2°C and +8°C).
Shake well before use.
Manufactured & Developed by:
Central Veterinary Research Laboratory
UAE